You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A capsule-based bioconjugate vaccine to prevent Klebsiella pneumoniae infections
SBC: VaxNewMO Topic: NIAIDPROJECT SUMMARY Klebsiella pneumoniae is an encapsulated human pathogen capable of causing a myriad of human infections. Recently, K. pneumoniae has also emerged as one the most common causes of secondary bacterial pneumonia in COVID-19 patients. Over the last 40 years, K. pneumoniae has evolved into two distinct pathotypes, known as classical K. pneumoniae (cKp) and hypervirulent K. pneumoniae (h ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies
SBC: NEWVENTUREIQ LLC Topic: 300PROJECT SUMMARY ABSTRACT More people die every year from kidney disease than breast or prostate cancerKidney transplantation is life saving but is limited by a shortage of organ donors and an unacceptably high donor organ discard rateThe decision to use or discard a donor kidney relies heavily on manual quantitation of key microscopic findings by pathologistsA major limitation of this microscopic ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies
SBC: NEWVENTUREIQ LLC Topic: 400ABSTRACT More people die every year from kidney disease than breast or prostate cancer. Kidney transplantation is life-saving, yet the donor organ shortage and high organ discard rate contributes to 13 deaths daily among patients awaiting transplant. The decision to use or discard a donor kidney relies heavily on microscopic quantitation of chronic damage by pathologists. The current standard of c ...
STTR Phase II 2020 Department of Health and Human ServicesNational Institutes of Health -
A Deep Learning Model to Quantify Arteriosclerosis in Donor Kidney Biopsies
SBC: NEWVENTUREIQ LLC Topic: 400ABSTRACT More people die every year from kidney disease than breast or prostate cancer. Kidney transplantation is life-saving, yet the donor organ shortage and high organ discard rate contributes to 13 deaths daily among patients awaiting transplant. The decision to use or discard a donor kidney relies heavily on microscopic quantitation of chronic damage by pathologists. The current standard of c ...
STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health -
ADENOVIRUS REPLICATION-COMPETENT ANTI-CANCER VECTOR
SBC: VIRRX, INC Topic: N/ADESCRIPTION (provided by applicant): We have developed several tumor-specific and tissue-specific replication-competent adenoviruses (Ad) vectors for cancer gene therapy. One vector, named KD3, has a mutation in the E1A gene such that KD3 cannot replicate in, and destroy, "normal" cells. However, KD3 can replicate in cancer cells because they have a microenvironment conducive to KD3 replication. ...
STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health -
ADENOVIRUS REPLICATION-COMPETENT ANTI-CANCER VECTOR
SBC: VIRRX, INC Topic: N/ADESCRIPTION (provided by applicant): We have developed several tumor-specific and tissue-specific replication-competent adenoviruses (Ad) vectors for cancer gene therapy. One vector, named KD3, has a mutation in the E1A gene such that KD3 cannot replicate in, and destroy, "normal" cells. However, KD3 can replicate in cancer cells because they have a microenvironment conducive to KD3 replication. ...
STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health -
A device containing an immobilized chelator to remove aluminum from total parente
SBC: ALKYMOS, INC Topic: NICHDDESCRIPTION (provided by applicant): A high percentage of the ~ 500,000 children born prematurely each year in the US require intravenous feeding after birth because they do not tolerate oral feeding. This is accomplished with a total parenteral nutrition (TPN) solution, which is prepared from component solutions: small and large volume parenterals (SVPs and LVPs). Aluminum (Al) is a common contam ...
STTR Phase II 2010 Department of Health and Human ServicesNational Institutes of Health -
A device containing immobilized chelator to remove aluminum from TPN solutions
SBC: ALKYMOS, INC Topic: N/ADESCRIPTION (provided by applicant): A high percentage of the ~ 470,000 children born prematurely each year in the US require intravenous feeding after birth because they do not tolerate oral feeding. This is accomplished with a total parenteral nutrition (TPN) solution, which is prepared from component solutions: small and large volume parenterals (SVPs and LVPs). Aluminum (Al) is a common conta ...
STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health -
Advancement of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC)
SBC: Accuronix Therapeutics Inc Topic: 102Project Summary Abstract Pancreatic cancer is a devastating disease with a very lowyear survival rateTherapeutic options are limited in efficacy and many have substantial toxicityTargeted drug delivery may improve the therapeutic index of cancer drugs by enhancing drug localization to the cancer cell while minimizing off target side effectsreceptors are highly expressed in pancreatic and other can ...
STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health -
A High Resolution Radiation Therapy Dosimetry system
SBC: DOSEIMAGING, LLC Topic: 399DESCRIPTION provided by applicant Modern radiation therapy treatment modalities such as intensity modulated radiation therapy are associated with complex dose distributions and sharp dose gradients Experimental dose validation using multidimensional high spatial resolution dosimeters is mandatory The product to be developed is a novel high resolution dosimetry system that combines reusabil ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health